Delivery Order SPE2DB22D2206-SPE2DB26FDQ71
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Albutein 5% in 250ml vials, with a ceiling value of $1,128.50. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $2,507.45 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Albutein 5% in 250mL vials. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting the contractor's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Albutein 5% vial 500ml, a pharmaceutical product commonly used in medical settings. This competitively awarded, firm fixed price delivery order has a ceiling value of $1,441.80 and an ultimate completion date of September 3, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.65 to AmerisourceBergen Drug Corp for Albutein 5% vials (250ml) under a firm fixed price contract type, with an ultimate completion date of September 4, 2025. This non-set-aside award was issued on August 13, 2025, with performance to be completed in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, serves as a...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,015.65, is for the supply of Albutein 5% vial (250 ml) medical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $1,150.00 to Amerisourcebergen Drug Corp's Corporate Office Division. This order is for 4565132903 - ALBUTEIN 25% VIAL 50ML, a pharmaceutical product. The award does not have a set-aside designation and is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
- This is a $1,441.80 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ALBUTEIN 5% VIAL 500ML, a pharmaceutical product, with a completion date of July 15, 2025. The contract is a firm fixed-price, non-set-aside award, meaning it was open to full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,154.16, is for the delivery of ALBUTEIN 5% VIAL 500ML medical supplies. The contract type is a Delivery Order with a Firm Fixed Price pricing structure and an ultimate completion date of March 29, 2024. This contract award is not designated as a set-aside. AmerisourceBergen holds a significant...
- This federal contract award, valued at $2,141.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ALBUTEIN 5% VIAL 250ML, a medical product, and is a firm fixed-price delivery order with a completion date of December 9, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,300.00, is for the supply of ALBUTEIN 5% VIAL 250ML, a medical product. The contract has an ultimate completion date of December 5, 2022 and was awarded on November 10, 2022. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDQ71Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,353.60 to AmerisourceBergen Drug Corp for Albutein 5% Vial 250ML on October 14, 2025, with an ultimate completion date of November 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive IDC vehicle to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. The broader SPE2DX prime vendor contract enables the company to support military healthcare programs worldwide by providing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to customers including the Defense Health Agency and U.S. Coast Guard. The delivery order for Albutein, a human serum albumin product used in medical and surgical applications, exemplifies the routine pharmaceutical supply fulfillment that occurs under this expansive federal contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/14/25 |